Erratum: The epidemiology of community-acquired clostridium difficile infection: A population-based study (American Journal of Gastroenterology (2012) 107 (89-95) DOI: 10.1038/ajg.2011.398);The epidemiology of community-acquired clostridium difficile infection: A population-based study

American Journal of Gastroenterology

Volumn 107, Issue 1, 2012, Pages 89-95

  Khanna, Sahil ^a   Pardi, Darrell S ^a   Aronson, Scott L ^a,b   Kammer, Patricia P ^a   Orenstein, Robert ^c   St Sauver, Jennifer L ^c   Harmsen, W Scott ^c   Zinsmeister, Alan R ^c  

^a MAYO CLINIC   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNICABLE DISEASE; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 84855422347     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.444     Document Type: Erratum

References (33)

1. Bartlett JG, Chang TW, Gurwith M et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. New Engl J Med 1978; 298: 531-4. (Pubitemid 8295586)
2. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359: 1932-40.
3. Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol 2010; 4: 409-16.
4. Centers for Disease Control and Prevention. Severe Clostridium difficileassociated disease in populations previously at low risk-four states, 2005. Morb Mortal Wkly Rep 2005; 54: 1201-5.
5. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442-9. (Pubitemid 41770165)
6. McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin genevariant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433-41. (Pubitemid 41770164)
7. Muto CA, Pokrywka M, Shutt K et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fl uoroquinolone use. Infect Control Hosp Epidemiol 2005; 26: 273-80. (Pubitemid 40445086)
8. Pépin J, Alary M-E, Valiquette L et al. Increasing risk of relapse aft er treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005; 40: 1591-7. (Pubitemid 40720808)
9. Warny M, Pepin J, Fang A et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366: 1079-84. (Pubitemid 41338761)
10. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-15.
11. Oake N, Taljaard M, Van Walraven C et al. The Effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med 2010; 170: 1804-10.
12. Dallal RM, Harbrecht BG, Boujoukas AJ et al. Fulminant Clostridium diffi-cile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235: 363-72. (Pubitemid 34183887)
13. Wilcox MH, Mooney L, Bendall R et al. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008; 62: 388-96. (Pubitemid 351984787)
14. Naggie S, Miller BA, Zuzak KB et al. A case-control study of communityassociated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med 2011; 124: 276 e1-7.
15. Fellmeth G, Yarlagadda S, Iyer S. Epidemiology of community-onset Clostridium difficile infection in a community in the South of England. J Infect Public Health 2010; 3: 118-23.
16. Melton III LJ. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 266-74.
17. St Sauver JL, Grossardt BR, Yawn BP et al. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. American J Epidemiol 2011; 173: 1059-68.
18. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83. (Pubitemid 17055592)
19. McDonald LC, Coignard B, Dubberke E et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28: 140-5. (Pubitemid 46374153)
20. Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
21. Centers for Disease C, Prevention. Surveillance for community-associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008; 57: 340-3.
22. Henrich TJ, Krakower D, Bitton A, et al. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 2009; 15: 415-22.
23. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficilerelated mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13: 1417-9. (Pubitemid 47510317)
24. Ricciardi R, Rothenberger DA, Madoff RD et al. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007; 142: 624-31; discussion 631. (Pubitemid 47080440)
25. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008; 14: 929-31. (Pubitemid 351838602)
26. Campbell RJ, Giljahn L, Machesky K et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009; 30: 526-33.
27. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173: 1037-42.
28. Zilberberg MD. Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis 2009; 15: 122-4.
29. Zilberberg MD, Shorr AF, Kollef MH. Increase in Clostridium difficilerelated hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J 2008; 27: 1111-3.
30. Pepin J, Valiquette L, Alary ME et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171: 466-72. (Pubitemid 39179608)
31. Gravel D, Miller M, Simor A et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis 2009; 48: 568-76.
32. Dubberke ER, Butler AM, Hota B et al. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol 2009; 30: 518-25.
33. Beaugerie L, Flahault A, Barbut F et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 2003; 17: 905-12. (Pubitemid 36459603)